Detalhe da pesquisa
1.
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
BMC Biol
; 22(1): 43, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378561
2.
Window-of-opportunity clinical trials for biomarker discovery in head and neck squamous cell carcinoma.
Curr Opin Oncol
; 35(3): 158-165, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966501
3.
Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511329
4.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Invest New Drugs
; 39(6): 1641-1648, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322775
5.
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.
Br J Cancer
; 123(10): 1481-1489, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839491
6.
Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study.
Crit Care Med
; 48(6): 822-829, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317596
7.
Molecular screening programs in different countries: what we learned and perspectives.
Curr Opin Oncol
; 31(5): 445-453, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31261171
8.
Hyperprogression under Immunotherapy.
Int J Mol Sci
; 20(11)2019 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151303
9.
Antibody drug conjugates: the future of chemotherapy?
Curr Opin Oncol
; 28(5): 429-36, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27366963
10.
CD74 supports accumulation and function of regulatory T cells in tumors.
Nat Commun
; 15(1): 3749, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702311
11.
Precision medicine strategies in oncology: mixed approaches to matched therapies.
Future Oncol
; 14(2): 105-109, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29224361
12.
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Cancer Rep (Hoboken)
; 6(5): e1804, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069784
13.
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Eur J Cancer
; 191: 112981, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506588
14.
CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade.
Oncoimmunology
; 12(1): 2246319, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37885970
15.
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Sci Rep
; 13(1): 22524, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110561
16.
Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.
Oncoimmunology
; 11(1): 2057396, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371620
17.
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer.
Clin Transl Sci
; 15(1): 55-62, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33742767
18.
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
Mol Oncol
; 16(16): 3001-3016, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398964
19.
Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 13(11)2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073885
20.
["Immunotherapy in head and neck squamous cell carcinoma"]. / Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire.
Rev Prat
; 71(4): 396-399, 2021 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-34161005